Delivery Order SPE2DR25D3401-SPE2DR26FL0EU
- Not listed
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $7,124.96 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,109.75 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors with a ceiling value of $11,074.20 and a firm fixed price structure. This delivery order, which is expected to be completed by November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $1,306.78 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and performance to be executed at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $27,603.52 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors, with a completion deadline of December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $54,899.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 15 mg/0.5 ml pen injections on November 25, 2025, with completion expected by November 26, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was awarded without...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $10,960.72 and an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,143.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 18, 2025. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a $35,060.94 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens under a firm fixed-price contract. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0EUDelivery Order
The Defense Logistics Agency awarded a $7,382.80 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with performance completion scheduled for December 2, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The contractor's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's IDC with DLA provides a flexible contracting vehicle enabling it to supply pharmaceutical products to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. This delivery order for Zepbound reflects routine pharmaceutical supply operations under that overarching contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 11/30/25 |